2/18/2010
Intezyne Announces Issuance of Seven Patents Covering Its IVECT Method
1/19/2010
Intezyne Featured in Gulf Coast Business Review
11/2/2009
Intezyne CSO Named Young Innovator of the Year
9/16/2009
Intezyne Wins Governor's Business Diversification Award
1/30/2008
Bright ideas corner cash at venture capital forum

Targeted Drug Delivery

Intezyne is a biotechnology corporation developing synthetic polymers for targeted drug delivery. For more information, please contact us at info@intezyne.com, and click on the following link to learn more about Our Technology.

Intezyne is an innovative and dynamic company employing a unique approach to solving the most important and complex problems associated with targeted drug delivery. By integrating the fields of organic and polymer chemistry, polymer physics, materials science, biochemistry, and biology, Intezyne is well-positioned to develop new polymeric biomaterials and drug delivery vehicles that will impact the millions of people worldwide who suffer from disease.

In contrast to the use of off-the-shelf polymers to develop "new" delivery technologies, Intezyne looks to design and chemically tailor novel polymers to address key problems in drug delivery. This fundamentally different strategy has led to the development of new heterobifunctional poly(ethylene glycol) (PEG) reagents and the IVECT™ drug delivery platform, a versatile system that addresses the diverse requirements for advanced drug delivery.
COMPANY PROFILE | OUR TECHNOLOGY | NEWS | INVESTORS | CONTACT US | INTEZYNE HOME
Intezyne © 2010